我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Genzyme/Geltex Pharmaceuticals Joint Venture

商品編號: UV0086
出版日期: 1999/04/20
作者姓名:
Bruner, Robert F.;Bodily, Samuel E;Jacquet, Pierre
商品類別: General management
商品規格: 12p

再版日期: 2016/06/29
地域:
產業:
個案年度: -  

 


商品敘述:

In March 1997, an executive vice president of Genzyme Corporation must develop the terms by which the $518 billion (revenue) firm will form a joint venture with a small biotechnology firm to make and market a new drug. The tasks for the decision-maker are to estimate the enterprise value of the new joint venture and to recommend how large an interest to acquire in the venture, and to determine what price to pay for that interest, and when. The case may be used to pursue some or all of the following objectives: (1) exercising analytical techniques, (2) introducing a framework for creating value and reducing risk, (3) exploring the impact on value of a hidden option (staged investing), and (4) visualizing risk and its implications.


涵蓋領域:

Finance and investing;Joint ventures;Risk analysis


相關資料:

, (UV0152), 18p, by Robert F. Bruner;
, (UV0201), 0p, by Robert F. Bruner;
, (UV2494), 37p, by Robert F. Bruner;
, (UV5465), 0p, by Robert F. Bruner